反应详情

To a solution of 6-bromo-N-(5-cyanopyridin-2-yl)-7-(dimethoxymethyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide (intermediate 2H, 171 mg, 0.396 mmol) in THF (5 ml) at −78° C., was added MeLi (1.6 M in Et2O, 0.247 ml, 0.396 mmol), the solution was stirred for 5 min. Then, n-BuLi (1.6 M in hexane, 0.272 ml, 0.435 mmol) was added and the solution was stirred for 20 min. Then, DMF (0.184 ml, 2.37 mmol) was added. The reaction mixture was stirred at −78° C. for 1.5 h and then allowed to warm to room temperature. The reaction mixture was poured into sat. aq. NH4Cl and extracted twice with DCM. The organic phase was then dried over Na2SO4, filtered and evaporated. The residue was purified by normal phase chromatography (12 g gold silica gel cartridge, heptanes/EtOAc 100:0 to 0:100). The N-(5-cyanopyridin-2-yl)-7-(dimethoxymethyl)-6-formyl-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide containing fraction were concentrated. The residue was dissolved in MeOH (1.5 ml) and DCM (1.5 ml) and treated with NaBH4 (5.32 mg, 0.141 mmol). The reaction mixture was stirred at room temperature for 30 min, then poured into sat. aq. NH4Cl and extracted with DCM (3×). The combined organic phases were then dried over Na2SO4, filtered and evaporated. The crude material was purified by normal phase chromatography (4 g silica gel cartridge, heptanes/EtOAc 100:0 to 0:100) followed by a reverse phase chromatography (13 g C18 cartridge, 0.1% TFA in water/acetonitrile 80:20 to 0:100). The product containing fractions were treated with sat. aq. Na2CO3, concentrated until the organic solvent had been removed extracted with DCM (3×). The combined organic layers were dried over Na2SO4, filtered and evaporated to give the title compound as a colorless resin. (UPLC-MS 3) tR 0.92 min; ESI-MS 384.1 [M+H]+.

1. stirringthe solution was stirred for 20 min
2. stirringThe reaction mixture was stirred at −78° C. for 1.5 h
3. extractionextracted twice with DCM
4. dry with materialThe organic phase was then dried over Na2SO4
5. filtrationfiltered
6. customevaporated
7. customThe residue was purified by normal phase chromatography (12 g gold silica gel cartridge, heptanes/EtOAc 100:0 to 0:100)
8. concentrationThe N-(5-cyanopyridin-2-yl)-7-(dimethoxymethyl)-6-formyl-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide containing fraction were concentrated
9. dissolutionThe residue was dissolved in MeOH (1.5 ml)
10. stirringThe reaction mixture was stirred at room temperature for 30 min
11. extractionextracted with DCM (3×)
12. dry with materialThe combined organic phases were then dried over Na2SO4
13. filtrationfiltered
14. customevaporated
15. customThe crude material was purified by normal phase chromatography (4 g silica gel cartridge, heptanes/EtOAc 100:0 to 0:100)
16. additionThe product containing fractions
17. additionwere treated with sat. aq. Na2CO3
18. concentrationconcentrated until the organic solvent
19. customhad been removed
20. extractionextracted with DCM (3×)
21. dry with materialThe combined organic layers were dried over Na2SO4
22. filtrationfiltered
23. customevaporated